insights_auto
Why is 524494 down 3.51%?
Dive Deeperchevron_right
524494:BOM
IPCA Laboratories Ltd
₹ 1,845.00
arrow_downward
-3.51%(-67.20) 1D
10-р сарын 16, 15:30:00 (GMT+5:30) · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524494...
Open
₹ 1,913.95
High
₹ 1,913.95
Low
₹ 1,812.60
Mkt. cap
468.21Т
Avg. vol.
27.90 мян
Volume
12.00 мян
Dividend
0.33%
Quarterly dividend
₹ 1.50
Ex-dividend date
2026 оны 8-р сарын 7
P/E ratio
35.74
52-wk high
₹ 2,039.30
52-wk low
₹ 1,252.95
EPS
₹ 51.63
Shares outstanding
126.35 сая
No. of employees
17 мян
Open
₹ 1,913.95
High
₹ 1,913.95
Low
₹ 1,812.60
Mkt. cap
468.21Т
Avg. vol.
27.90 мян
Volume
12.00 мян
Dividend
0.33%
Quarterly dividend
₹ 1.50
Ex-dividend date
2026 оны 8-р сарын 7
P/E ratio
35.74
52-wk high
₹ 2,039.30
52-wk low
₹ 1,252.95
EPS
₹ 51.63
Shares outstanding
126.35 сая
No. of employees
17 мян
News stories
From web sources and news partners
Quiver Quantitative
·
40 минутын өмнө
Private Bancorp of America Reports Third Quarter 2026 Net Income of $11.4 Million and Diluted EPS of $1.97 as Deposits and Loans Grow After NASDAQ Uplisting
www.marketscreener.com
·
22 минутын өмнө
TruGolf Holdings Inc. (NASDAQ: TRUG) Acquisition Positions Company in Market for Regulated Tokenization, Digital Securities Infrastructure
The Daily News | Texas' Oldest Newspaper
·
49 минутын өмнө
FILE PHOTO: Signage is seen outside the New York Stock Exchange (NYSE) in Manhattan, New York City
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
About IPCA Laboratories Ltd
CEO-
Employees17.2 мян
Founded1949 оны 10-р сарын 19
Headquarters-
SectorPharmaceutical industry
Websiteipca.com